Medical Insights

Therapeutic Challenges in Metastatic Non-small Cell Lung Cancer (NSCLC) With Concurrent Mesenchymal-Epithelial Transition Factor (MET) Amplification and High Programmed Death- Ligand 1 (PD-L1) Express

D

Dr. Md. Arifur Rahman

Oncology Specialist

Therapeutic Challenges in Metastatic Non-small Cell Lung Cancer (NSCLC) With Concurrent Mesenchymal-Epithelial Transition Factor (MET) Amplification and High Programmed Death- Ligand 1 (PD-L1) Express

Delighted to share our latest case study published today in Cureus (Springer Nature)! Read the full open-access article: DOI: 10.7759/cureus.115338 Grateful to my co-authors and the multidisciplinary team at Bangladesh Specialized Hospital PLC for their collaboration on this longitudinal report. hashtag#Oncology hashtag#LungCancer hashtag#NSCLC hashtag#PrecisionOncology hashtag#Radiotherapy hashtag#Cureus hashtag#MedicalResearch hashtag#GenomicProfiling hashtag#BSHL hashtag#BSBCS hashtag#OncoEdu